An adaptive phase ii/iii safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of trichuris trichiura and other sth infections

HIGHLIGHTS

• who: Antihelmintics et al. from the Barcelona Institute for Global Health (ISGlobal), Hospital Clu00ednic-Universitat de Barcelona, Barcelona, Spain Instituto de Investigaciones de Enfermedades Tropicales, Universidad Nacional de Salta, Oran, Salta, Argentina have published the research: An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections, in the Journal: (JOURNAL) of 05/05/2022
• what: The study protocol presented in this report summarizes the progress and achievements leading to the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.